Bull
$244.79
Scenario price
$129.550
+1.049 (+0.81%)At close
Houlihan Lokey, Inc. is a global investment bank specializing in mergers and acquisitions, capital solutions, financial restructuring, and financial and valuation advisory. Its segments include Corporate Finance (CF), Financial Restructuring (FR), and Financial and Valuation Advisory (FVA). CF segment provides general financial advisory services and advice on mergers and acquisitions and capital solutions offerings. FR segment offers a range of advisory services to its clients, including: the structuring, negotiation, and confirmation of plans of reorganization; liability management transactions; corporate viability assessment, and procuring debtor-in-possession financing. FVA segment provides financial advisory and valuation services with respect to companies, debt and equity interests (including complex illiquid investments), and other types of assets and liabilities, and others. It also provides investment banking advice to clients in the insurance and wealth management sectors.
Houlihan Lokey Inc is currently a hold. The stock is priced at $129.55, which is below the average analyst price target of $165, indicating potential upside. However, the stock has experienced a significant year-to-date decline of 26.53%, and hedge funds have increased their selling activity by 102.34% over the last quarter, which raises concerns about short-term momentum. Additionally, the RSI is at 55.949, suggesting that the stock is neither overbought nor oversold, indicating a neutral position. Therefore, while there is potential for recovery, the current market sentiment and selling pressure suggest caution before making a buy decision.
BofA
$150
2026-10-12
BofA
2026-10-12
Price Target
$150
Citizens
$175
2026-10-09
Citizens
2026-10-09
Price Target
$175
Morgan Stanley
$165
2026-10-08
Morgan Stanley
2026-10-08
Price Target
$165
Keefe Bruyette
$150
2026-10-07
Keefe Bruyette
2026-10-07
Price Target
$150
UBS
$154
2026-10-07
UBS
2026-10-07
Price Target
$154
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

Latest Wall Street Ratings Overview

Houlihan Lokey to Release Q2 FY2027 Results on October 28, 2026

Jane Ma Joins Houlihan Lokey as Managing Director

Houlihan Lokey Appoints New Chief Legal Officer

Houlihan Lokey Opens New Office in West Palm Beach
Houlihan Lokey, Inc. is a global investment bank specializing in mergers and acquisitions, capital solutions, financial restructuring, and financial and valuation advisory. Its segments include Corporate Finance (CF), Financial Restructuring (FR), and Financial and Valuation Advisory (FVA). CF segment provides general financial advisory services and advice on mergers and acquisitions and capital solutions offerings. FR segment offers a range of advisory services to its clients, including: the structuring, negotiation, and confirmation of plans of reorganization; liability management transactions; corporate viability assessment, and procuring debtor-in-possession financing. FVA segment provides financial advisory and valuation services with respect to companies, debt and equity interests (including complex illiquid investments), and other types of assets and liabilities, and others. It also provides investment banking advice to clients in the insurance and wealth management sectors. It operates in the Financials sector (INVESTMENT ADVICE industry).
Houlihan Lokey Inc is currently a hold. The stock is priced at $129.55, which is below the average analyst price target of $165, indicating potential upside. However, the stock has experienced a significant year-to-date decline of 26.53%, and hedge funds have increased their selling activity by 102.34% over the last quarter, which raises concerns about short-term momentum. Additionally, the RSI is at 55.949, suggesting that the stock is neither overbought nor oversold, indicating a neutral position. Therefore, while there is potential for recovery, the current market sentiment and selling pressure suggest caution before making a buy decision.
7 analysts cover HLI: 4 rate it Buy, 3 Hold and 0 Sell. The average price target is 215.50.
No posts yet
Sign up or log in to join the discussionThis page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.